Value of (18)F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients

PURPOSE: Epidermal growth factor receptor (EGFR) mutations and the anaplastic lymphoma kinase (ALK) rearrangement are the two most common druggable targets in non-small cell lung cancer (NSCLC). However, genetic testing is sometimes unavailable. Previous studies regarding the predictive role of (18)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhilei, Fan, Jinshuo, Xu, Juanjuan, Wu, Feng, Huang, Qi, Guo, Mengfei, Liao, Tingting, Liu, Shuqing, Lan, Xiaoli, Liao, Shanshan, Geng, Wei, Jin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978918/
https://www.ncbi.nlm.nih.gov/pubmed/29164298
http://dx.doi.org/10.1007/s00259-017-3885-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978918/
https://www.ncbi.nlm.nih.gov/pubmed/29164298
http://dx.doi.org/10.1007/s00259-017-3885-z

Ejemplares similares